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Summary
Objective of this study was to provide data on hospitalizations 
for rotavirus gastroenteritis (RVGE) in Ferrara, Italy.
The study was conducted analyzing the hospital discharge forms 
of all children admitted to the Pediatric Department of the Uni-
versity of Ferrara, Arcispedale Sant’Anna, from January 2001 
through December 2005. The database was searched for all 
gastrointestinal diseases and in particular RVGE.
During the period under study 3277 children, of which 2038 < 60 
months of age, were hospitalized; 247 children < 5 years old were 
admitted for acute gastroenteritis and 89 (4.4% of all and 36% of 
gastroenteritis-related hospitalizations) had rapid screening tests 
positive for rotavirus. A seasonal pattern was observed for RVGE 
with an increase in winter and early spring. The average length of 
hospital stay was 5.7 days. The median cost of each hospitalized 
case of RVGE ranged between 1417 and 1595 €.
The present research confirms that rotavirus gastroenteritis rep-
resents an important cause of hospitalization in children and is 
responsible for significant costs for the Public Health Care Sys-
tem. An effective vaccination program could significantly reduce 
the incidence of hospitalization and the associated costs.
Introduction
rotavirus represents the main cause of acute gastroen-
teritis (Ge) in children worldwide [1, 2]. virtually every 
child will be infected by rotavirus before age 3-5, some 
of them more than once in this period of time [1].
Clinically, the infection can vary from the asymptomatic 
form to the severe one with dehydration, which, if not 
adequately treated, can be fatal. in comparison to other 
viruses, rotaviruses (rv), usually, determine a more 
severe diarrhea, often associated to dehydration; never-
theless, there is no way of foreseeing the gravity and 
the evolution of the disease [1, 3]. rv are endemic in 
both developing and industrialized countries, and their 
transmission is independent from social-economic and 
hygienic-sanitary conditions [1].
Globally, it is estimated that every year rv are re-
sponsible for over 125 million cases of acute Ge in 
children and 600,000 deaths, which mostly (82%) 
occur in developing countries [2, 4]. in industriali-
zed countries, the possibility to access to equipped 
healthcare centers and consequently receive adequate 
treatments correlates to a low mortality (about 231 
deaths/year in europe) and a higher hospitalization 
incidence rate [4].
in europe it is estimated that every year 3.6 million 
cases of rotavirus gastroenteritis (rvGe), 87,000 hospi-
talization and more than 700,000 clinic visits occur, on a 
total of 23.6 million children under 5 years of age [5].
epidemiological studies in italy indicate that rv are re-
sponsible on the average for 26% of hospital admissions 
in children [6, 7].
Considering that rv are also an important cause of no-
socomial infections in children and health care workers, 
rvGe represent a considerable problem for public 
health care systems with a significant impact, even in 
economical terms (direct and indirect costs), on society 
and families [8].
two new live attenuated oral vaccines are available 
on the world market. Considering the microbiological 
characteristics of rv, these vaccines represent the most 
effective system to prevent moderate/severe forms of 
rvGe and, therefore, to contain the associated costs.
the purpose of this study was to provide data on hospi-
talization of children with acute gastrointestinal disea-
ses, in particular rotavirus gastroenteritis, in Ferrara, 
italy.
Materials and methods
the study was conducted in the Pediatric Department of 
the University of Ferrara, Arcispedale Sant’Anna, Italy; 
this institute has 12 beds and covers a population of 
20,933 children and adolescents between 0 and 18 years 
of age, of which 6,759 under 60 months.
in this retrospective study we analyzed the hospital di-
scharge forms (sDo) of all children between 0-18 years 
old admitted to the Pediatric Department from January 
2001 through December 2005.
Hospital discharge forms represent an important in-
strument, which provides information about every pa-
tient discharged from all public and private hospitals 
nationwide; they are filled out by the physicians who 
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had the patient in care and contain information regar-
ding clinical (diagnosis, relevant symptoms, surgery, 
diagnostic and therapeutic procedures, prosthetic im-
plants, discharge status) and organizational aspects of 
the hospitalization (hospital division of admission and 
discharge, transfers to other wards, expected source of 
payment). the hospital discharge forms are then coded 
and transmitted to the regions and from these to the 
national Ministry of Health [9].
Hospitalization records for gastrointestinal diseases 
were selected. the hospital database was searched to 
investigate all intestinal infections, using iCD codes: 
cholera (iCD 001), typhoid and paratyphoid fever (iCD 
002), other salmonella infections (iCD 003), shigellosis 
(iCD 004), other food poisonings (iCD 005), amebiasis 
(iCD 006), other protozoal intestinal diseases (iCD 
007), bacterial intestinal infections (iCD 0080, 0081, 
0082, 0083, 0084, 0085), enteritis due to specified virus 
(iCD 0086), intestinal infections due to other organism 
not classified elsewhere (iCD 0088), ill-defined intesti-
nal infections (iCD 009). For rv enteritis the iCD code 
used is 00861, belonging to enteritis due to specified vi-
rus. in the same class we also searched for enteritis due 
to other viruses: adenovirus (iCD 00862), enterovirus 
neC (not elsewhere Classified) (iCD 00867) and other 
viral enteritis (iCD 00869).
Demographic-anamnestic (particularly age and gender) 
and clinical data (symptoms, length of stay, diagnosis at 
admission, concomitant disease) were obtained anony-
mously for each patient.
Data were stratified by age (0-6 months, 7-12 months, 
13-24 months, 25-36 months, 37-60 months, > 60 mon-
ths), gender and symptoms (diarrhea and/or fever and/or 
vomiting and/or dehydration).
Diagnosis of rotavirus infection was confirmed in the 
Microbiology laboratory through rapid immuno-chro-
matographic tests on stool specimens obtained in the 
Pediatric Department. the determination of costs rela-
ted to hospitalizations was evaluated through Diagnosis 
related Group (DrG) rates.
according to the DrG reimbursement system, every 
hospitalized patient belongs to a group of diagnostical-
ly homogeneous cases; therefore patients within each 
category are similar clinically and are expected to use 
the same level of hospital resources. as a result patien-
ts in the same DrG group are assigned the same reim-
bursement charges. in case of outliers (patients with a 
length-of-stay superior or inferior to that individually 
established for every DrG), the cost-weight increases 
or decreases for every day more or less compared to 
the average length-of-stay [10].
a specific DrG for rotavirus gastroenteritis does not 
exist, therefore DrG 184 (esophagitis, gastroenteritis, 
and miscellaneous digestive disorders, age < 18) and 
298 (nutritional and miscellaneous metabolic disorders, 
age < 18) were assigned to patients discharged from the 
Pediatric Department, referring to the emilia romagna 
regional DrG reimbursement system (HCFG-DrG 
19th version, 2005).
Results
From January 2001 through December 2005, 3,277 
children were admitted to the Pediatric Department, of 
which 2,038 < 60 months of age; 12.1% (247) of the 
patients had symptoms referable to a gastroenteritis.
Most (53.4%) discharges for gastrointestinal disease 
were classified as ill-defined intestinal infections (iCD 
009): infectious (iCD 0090) or presumed infectious 
(iCD 0091) colitis, enteritis, and gastroenteritis and in-
fectious (iCD 0092) or presumed infectious (iCD 0093) 
diarrhea.
viral enteritis represented 45.7% of admissions for 
gastrointestinal disease, while only 0.9% were due to 
other organisms.
rotaviruses were responsible for 78.8% of viral enteri-
tis, followed by adenovirus (16.8%), enterovirus neC 
(2.7%) and other viruses (1.7%).
Considering all admissions of children from 0 to 18 
years old in the period of time studied, positivity of 
rapid tests for rotavirus and adenovirus was obtained 
in 120 and 25 cases, respectively. regarding children 
< 5 years old, 89 cases were found positive for ro-
tavirus and 19 for adenovirus, which correspond to 
4.4% and 0.9% of all admissions and 36% and 7.7% 
of admissions for acute gastroenteritis, respectively 
(tab. i).
Tab. I. admissions (< 60 months of age) to the Pediatric department in Ferrara, 2001-2005.
 Total  GE-associated Rotavirus Adenovirus  % GE-associated 
 admissions admissions positive GE positive GE  admissions
  N % total N % total N % total RV AV
   admissions  admissions  admissions positive positive
2001 356 51 14.3 13 3.7 1 0.3 25.5 2
2002 435 61 14 25 5.7 2 0.5 41 3.3
2003 397 19 4.8 10 2.5 3 0.8 52.6 15.8
2004 396 36 9.1 15 3.9 9 2.3 41.7 25
2005 454 80 16.5 26 5.7 4 0.9 32.5 5
total 2038 247 12.1 89 4.4 19 0.9 36 7.7
N = number; ge = gastroenteritis; rv = rotavirus; av = adenovirus
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the annual incidence rate of hospitalization for rvGe, 
referred to the Pediatric Department’s population, was 
2.6/1000 children < 60 months of age; the estimated 
average cumulative incidence rate for rvGe hospitali-
zations was 1 in 74 children.
the number of monthly admissions was nearly constant, 
while admissions for acute gastroenteritis showed an 
increase in winter and spring and an evident reduction 
in summer, with the highest hospitalization rate for Ge 
in april (29.2%) and the lowest in June (2%). rvGe 
hospitalizations also showed a seasonal pattern, with an 
increase in winter and spring (maximum peak 12.9% in 
april) and a decrease in summer and autumn (minimum 
peak 0.6% in June) (Fig. 1).
regarding the age of the patients (Fig. 2), 74.2% 
(89/120) of rvGe hospitalizations involved children 
below 5 years old; admissions for rvGe were more 
frequent in males (60%). in children < 5 yrs, 34.8% 
(31/89) of cases occurred within the first 12 months of 
life and the remaining 65.2% (58/89) between 12 and 
60 months.
Considering children < 60 months of age, diarrhea was 
present in all cases. vomiting and fever were described 
in 73.7% and 62.4% of the cases, respectively. the si-
multaneous observation of diarrhea, vomiting and fever 
occurred in 63% of patients. these symptoms led to 
dehydration in 64% of cases. in 25% of these patients a 
co-morbidity was found (acute upper and lower respira-
tory infections, urinary tract infections, seizures, growth 
retardation, iron deficiency anemia, etc.).
rotavirus gastroenteritis was responsible for about 101 
days of hospitalization per year, with an average length 
of hospital-stay of 5.7 days. this length of stay was lon-
ger than that for adenovirus gastroenteritis (4.8 days).
Concerning the economic impact of rotaviral disease, 
using the emilia romagna regional reimbursement 
charges (HCFG-DrG 19th version, 2005), the median 
cost for each hospitalized case of rvGe ranged from 
1417.44 € (DRG 298) to 1595.05 € (DRG 184). In 
2005, 1 outlier case of rotavirus disease was observed, 
for which the DrG 298 charge was applied with a daily 
increase of 218.77 € (total 1636.2 €).
noteworthy, 31 (25.8%) cases of rvGe were observed 
in children and adolescents 5-16 years old, accounting for 
9.5% of the hospitalizations for diarrhea in patients aged 
between 0 and 16 years. the median age for these cases was 
8.1 years old and 96% of them presented co-morbidities.
Discussion and conclusions
the availability of anti-rotavirus vaccines has stimulated 
numerous studies to determine both the epidemiological 
and social-economic impact of this disease. However, 
rotavirus infections in italy, as in other countries, are 
not subject to a specific active surveillance system, thus 
it is difficult to obtain an accurate evaluation of the in-
cidence of the disease.
Hospital discharge forms, even though with some limits, 
represent a valid instrument for the measurement of ho-
spitalization rates and for the estimate of the incidence 
of a specific illness, including rotavirus gastroenteritis. 
in the present study it was possible to consult the data-
base not only for the main diagnosis, which often deter-
mines underestimation of rotavirus infections, but even 
for the secondary ones.
this study confirms that acute gastroenteritis is an im-
portant cause of hospital admission in children < 5 years 
old. researches conducted locally [6, 11, 12] and natio-
nally [7, 13] show that rotaviruses are on the average 
responsible for 26% of all diarrhea-associated hospitali-
zations in children. in particular a recent analysis, whi-
ch consulted the national hospital discharge database, 
found that rotaviruses are responsible for about 17% of 
all hospitalizations for intestinal infections and 84% of 
hospitalizations for viral enteritis [13]. the first percen-
tage is significantly lower than the one registered in this 
(36%) and in other italian studies [7, 14], even though 
the rate of cases coded as ill-defined intestinal infec-
tions was similar (54% vs 53.4%) in both researches. 
international active surveillance studies, conducted in 
hospitals, have found that rotaviruses are present in 
about 35-60% of stool specimens from children with 
diarrhea [15-18].
Fig. 1. temporal pattern of ge-associated 
hospitalizations in the Pediatric depart-
ment of Ferrara, 2001-2005.
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in the 25 countries of the european union, a median 
of 40% of hospitalizations for acute gastroenteritis in 
children < 5 years of age are attributable to rotavirus 
infections. in this age group it is estimated that the me-
dian incidence rate is equal to 3/1000 children per year 
and that 1 child out of 67 is hospitalized for rvGe [4]. 
these rates are similar to the ones registered in this study 
(2.6/1000 and 1 in 74 children < 5 years of age, respec-
tively).
as reported in literature [7, 19], even in Ferrara the exi-
stence of a seasonal pattern for rvGe was confirmed, 
with a higher incidence in winter and early spring. as 
described by other authors [4, 7, 20-23], the highest in-
cidence was found in children between 6 and 24 months 
of age with a prevalence in males.
rotavirus infections have actually been described in all 
age groups, including adults. as in the present study, 
cases of rvGe have been observed by other authors in 
children over 5 years old, with an incidence rate ranging 
from 16% to 25% [14, 24, 25].
the average length of hospital stay in italy is 4 days [13], 
about 1.5 days shorter than the stay registered in Ferrara. 
However, analyzing the population by symptoms, we 
found that cases of rvGe with dehydration, vomiting 
and/or fever had an average length-of-stay of 4.4 days; 
the median length of stay rose to 7.4 days for patients 
with co-morbidities.
the data collected in this study refers to community-
acquired infections. However, the importance of noso-
comial rotavirus infections is well known; these involve 
younger children (0-5 months) and determine a longer 
hospital stay. even nosocomial rotavirus infections are 
highly seasonal, occurring mainly in winter; this coin-
cides with the peak of other viral infections (especially 
respiratory infections) and contributes to overloading 
and overcrowding hospital wards [19, 26].
in industrialized countries, like italy, rotavirus in-
fections generate significant costs for health care 
systems, families and society. Hospitalization costs 
relate to hospital stay, professional services, labora-
tory exams and treatments [8]. in europe the average 
cost of each hospitalized case ranges, according to 
the country, from 691 € in Poland to 1773 € in Spain 
(median: 1417 €) [4]. Similarly, in the present resear-
ch the average cost reimbursed for each hospitalized 
case ranged between 1417 and 1595 €. According 
to a recent study, in italy the total estimated cost of 
hospitalized cases ranges from 6 to 8 million €/year, 
bearing in mind the limit of the absence of a specific 
DrG for rvGe and the underestimation of the etio-
logically ill-defined cases [13]. to these we must add 
the costs for families and society of outpatient cases, 
which according to a recent study, could be estimated 
between 27 and 68 million € [27].
if the burden of rvGe is considered both in epide-
miological and economic terms, as shown by the most 
recent data available in literature and confirmed by 
this study, it is understandable why the World Health 
Fig. 2. characteristics of rvge hospi-
talized children.
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organization emphasizes the importance of preventing 
this disease.
Considering the insufficient impact of the hygienic-
sanitary measures usually adopted to limit diffusion of 
fecal-oral diseases [13, 19, 26], the development of safe 
and effective vaccines which prevent the moderate or 
severe complications of rotaviral infections, especially 
dehydration, is considered a priority.
today we have vaccines which respond to standards 
for safety and effectiveness and can be used in the 
battle against rotaviral infections by protecting from 
moderate/severe forms of rotavirus-related diarrhea. 
the extensive use of the vaccination could reduce 
mortality, still very high in developing countries, and 
hospitalizations and related costs in industrialized 
countries.
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